drugset / Trial / NCT02108782
Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors
Phase 2
Withdrawn
Academic and Community Cancer Research United
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
This phase II trial studies how well dovitinib lactate works in treating patients with pancreatic neuroendocrine tumors. Dovitinib lactate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dovitinib | Small molecule | — | Oral |